Smartwatches warn of disease spurts at Crohn's disease!

Smartwatches warn of disease spurts at Crohn's disease!

In a groundbreaking study,

scientists from the United States showed that portable technologies, especially smartwatches and fitness trackers, can warn up to seven weeks in advance of acute deteriorations in Crohn's disease and ulcerative colitis. This findings, published in the "Gastroenterology" journal, open up new opportunities for the early detection of health crises and could significantly improve the therapy of this chronic inflammatory bowel diseases. The early identification of bumps could be possible to avoid serious complications, reports OE24.

As part of the study, 309 participants wore portable devices for at least eight hours a day. These technologies recorded various physiological measurements such as heart rate, resting frequency, heart rate variability, daily steps and the oxygen saturation of the blood. In addition, comprehensive data from medical laboratory examinations were obtained, including inflammatory parameters such as the C-reactive protein. The participants also led diaries about their subjective state of health. All of this happened over a period of about seven months, which made the data evaluation particularly meaningful.

important knowledge for patient care

The results of the study showed significant changes in heart rate variability, heart rate, resting pulse, steps of steps and oxygen saturation up to seven weeks in advance before disease lows were registered. The change in heart rate variability (HRV), which is considered an indicator of general health, was particularly impressive. High HRV values ​​indicate good health, while circadian patterns of the HRV significantly varied between batches and phases of the subscription. During the acute phases of the disease, increasing values ​​were found for pulse frequency and resting pulse as well as a decrease in the daily steps.

chronic inflammatory bowel diseases (CED) such as Crohn's disease and ulcerative colitis affect millions of people worldwide. According to [Uchicago Medicine] (https://www.uchicagomedicine.org/forefront/gastrontestinal-articles/ibd-wearable-devices-drugs- and-at-home monitoring), up to three million patients are affected. Experts observe the developments in the use of portable devices that not only serve for physiological monitoring, but also for the analysis of inflammation in the intestine. Planned new therapies, including oral medication and biosensors in portable devices, could revolutionize the treatment of these diseases.

perspectives for a better quality of life

The integration of these technologies into the treatment process can help patients quickly recognize whether their therapy works or whether inflammatory processes are active. This promotes proactive health surveillance. In addition, nutrition plays an increasingly central role, which underlines the need for tailor -made nutritional plans for patients. These plans aim to take into account specific needs of the patients and are in the context of the latest studies on the effects of nutrition on chronic inflammatory bowel diseases.

In the Clinic for CED, individually adapted therapy concepts are of central importance. Both Crohn's disease and ulcerative colitis are autoimmune diseases that can attack the intestine and lead to inflammation, ulcers and other symptoms. The exact cause of these diseases has so far been unknown, and the course takes place in typical bumps, with phases of improvement and deterioration change. The collaboration between the clinic and the polyclinic is crucial to look after every patient as best as possible, as [https://www.ukr.de/chirurgie/feitungspeklungs spectrum/chronon-entlichen- darmer diseases).

Details
OrtUniversitätsklinikum Regensburg, Deutschland
Quellen

Kommentare (0)